The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know ...

Coherus BioSciences, Inc.’s CHRS share price has surged by 6.25%, which has investors questioning if this is right time to sell.

As the FDA prepares for a busy Oncologic Drugs Advisory Committee meeting next week, an agency insider told BioSpace that ...

Unresolved Treatment Needs in IPF. Idiopathic Pulmonary Fibrosis (IPF) is a progressive, irreversible, and fatal interstitial lung disease characterized ...

Goodnight’s ongoing decision to keep SAS private has shaped the company that — more than any other — has shaped the town of ...

The analysis by Ontada tracked testing rates withing the US Oncology Network for PD-L1, FGFR2/3, and HER2 biomarkers over 10 years.